Between disputed claims, unconstitutional payments and the new global push for higher prices, the PBS rebate system sits on increasingly shaky ground. It has delivered access and spending control, and might be more important than ever, given global shifts by US frustration, but it has the appearance of a complete mess.
What next for PBS rebate system amid constitutional breaches, disputed claims, and global pressure?
November 6, 2025 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
An institution dominated by very clever people, but where is the wisdom?
August 14, 2026 - - Latest News -
A plain language version of these dreadful and useless documents
August 14, 2026 - - Latest News -
CUREator+ backs six Australian startups with $13.5 million to advance new health technologies
August 13, 2026 - - Australian Biotech -
Medicines Australia appoints former AbbVie executive to key leadership role
August 13, 2026 - - Latest News -
VVMF and Optosleep partner to advance Australian gene therapy for sleep apnoea
August 13, 2026 - - Latest News -
Survey exposes deep gaps in neurological care across Australia
August 13, 2026 - - Latest News -
Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product
August 13, 2026 - - Latest News

